Rain Oncology Inc (NAS:RAIN)
$ 1.21 0 (0%) Market Cap: 44.02 Mil Enterprise Value: -32.85 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 22/100

Q3 2022 Rain Therapeutics Inc Earnings Call Transcript

Nov 10, 2022 / 10:00 PM GMT
Release Date Price: $5.78 (-0.52%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RAIN.OQ^A24 - Rain Oncology Inc
Q3 2022 Rain Therapeutics Inc Earnings Call
Nov 10, 2022 / 10:00PM GMT

=====================
Conference Call Participants
=====================
* >>Avanish Vellanki - CEO
* >>Robert Doebele - President
* >>Richard Bryce - Senior Key Executive
* >>Nelson Cabatuan - CFO
* >>Michael Schmidt - Guggenheim Securities, LLC, Research Division
* >>Yigal Nochomovitz - Citigroup Inc., Research Division
* >>Jeffrey Jones - Oppenheimer & Co. Inc., Research Division
* >>Mitchell Kapoor - H.C. Wainwright & Co, LLC, Research Division
* >>Soumit Roy - JonesTrading Institutional Services, LLC, Research Division

=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------

Greetings, and welcome to the Rain Therapeutics Third Quarter
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot